Borderline Ankle-Brachial Index Value of 0.91–0.99 Is Associated With Endothelial Dysfunction
Background: An ankle-brachial index (ABI) value of 0.91–0.99 is considered borderline and associated with an increased risk of cardiovascular events. However, there is no information on the relationship between borderline ABI and endothelial function. Methods and Results: We measured ABI and assesse...
Saved in:
| Published in | Circulation Journal Vol. 78; no. 7; pp. 1740 - 1745 |
|---|---|
| Main Authors | , , , , , , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
Japan
The Japanese Circulation Society
2014
|
| Subjects | |
| Online Access | Get full text |
| ISSN | 1346-9843 1347-4820 1347-4820 |
| DOI | 10.1253/circj.CJ-14-0165 |
Cover
| Abstract | Background: An ankle-brachial index (ABI) value of 0.91–0.99 is considered borderline and associated with an increased risk of cardiovascular events. However, there is no information on the relationship between borderline ABI and endothelial function. Methods and Results: We measured ABI and assessed vascular function by flow-mediated vasodilation (FMD) and nitroglycerin-induced vasodilation in 389 subjects who underwent health examinations. Subjects were divided into 3 groups according to ABI (normal group: 1.00–1.40, borderline group: 0.91–0.99, abnormal group: ≤0.90 or >1.40). FMD was significantly smaller in both the borderline and the abnormal group than in the normal group. There was no significant difference in the vascular responses to nitroglycerin between the normal and borderline groups. Vascular response to nitroglycerin was significantly higher in the normal group than in the abnormal group. Borderline and abnormal ABI values were significantly associated with an increased odds ratio of low tertile of FMD levels, using the normal ABI group as the reference. Multiple logistic regression analysis for FMD revealed that age, sex, hypertension, diabetes mellitus, and borderline ABI independently remained associated with FMD. Conclusions: ABI of 0.91–0.99 is associated with endothelial dysfunction. ABI examination is a simple and cost-effective method for obtaining the additional information on the initial step of atherosclerosis beyond the assessment of peripheral artery disease. (Circ J 2014; 78: 1740–1745) |
|---|---|
| AbstractList | An ankle-brachial index (ABI) value of 0.91-0.99 is considered borderline and associated with an increased risk of cardiovascular events. However, there is no information on the relationship between borderline ABI and endothelial function.
We measured ABI and assessed vascular function by flow-mediated vasodilation (FMD) and nitroglycerin-induced vasodilation in 389 subjects who underwent health examinations. Subjects were divided into 3 groups according to ABI (normal group: 1.00-1.40, borderline group: 0.91-0.99, abnormal group: ≤0.90 or >1.40). FMD was significantly smaller in both the borderline and the abnormal group than in the normal group. There was no significant difference in the vascular responses to nitroglycerin between the normal and borderline groups. Vascular response to nitroglycerin was significantly higher in the normal group than in the abnormal group. Borderline and abnormal ABI values were significantly associated with an increased odds ratio of low tertile of FMD levels, using the normal ABI group as the reference. Multiple logistic regression analysis for FMD revealed that age, sex, hypertension, diabetes mellitus, and borderline ABI independently remained associated with FMD.
ABI of 0.91-0.99 is associated with endothelial dysfunction. ABI examination is a simple and cost-effective method for obtaining the additional information on the initial step of atherosclerosis beyond the assessment of peripheral artery disease. An ankle-brachial index (ABI) value of 0.91-0.99 is considered borderline and associated with an increased risk of cardiovascular events. However, there is no information on the relationship between borderline ABI and endothelial function.BACKGROUNDAn ankle-brachial index (ABI) value of 0.91-0.99 is considered borderline and associated with an increased risk of cardiovascular events. However, there is no information on the relationship between borderline ABI and endothelial function.We measured ABI and assessed vascular function by flow-mediated vasodilation (FMD) and nitroglycerin-induced vasodilation in 389 subjects who underwent health examinations. Subjects were divided into 3 groups according to ABI (normal group: 1.00-1.40, borderline group: 0.91-0.99, abnormal group: ≤0.90 or >1.40). FMD was significantly smaller in both the borderline and the abnormal group than in the normal group. There was no significant difference in the vascular responses to nitroglycerin between the normal and borderline groups. Vascular response to nitroglycerin was significantly higher in the normal group than in the abnormal group. Borderline and abnormal ABI values were significantly associated with an increased odds ratio of low tertile of FMD levels, using the normal ABI group as the reference. Multiple logistic regression analysis for FMD revealed that age, sex, hypertension, diabetes mellitus, and borderline ABI independently remained associated with FMD.METHODS AND RESULTSWe measured ABI and assessed vascular function by flow-mediated vasodilation (FMD) and nitroglycerin-induced vasodilation in 389 subjects who underwent health examinations. Subjects were divided into 3 groups according to ABI (normal group: 1.00-1.40, borderline group: 0.91-0.99, abnormal group: ≤0.90 or >1.40). FMD was significantly smaller in both the borderline and the abnormal group than in the normal group. There was no significant difference in the vascular responses to nitroglycerin between the normal and borderline groups. Vascular response to nitroglycerin was significantly higher in the normal group than in the abnormal group. Borderline and abnormal ABI values were significantly associated with an increased odds ratio of low tertile of FMD levels, using the normal ABI group as the reference. Multiple logistic regression analysis for FMD revealed that age, sex, hypertension, diabetes mellitus, and borderline ABI independently remained associated with FMD.ABI of 0.91-0.99 is associated with endothelial dysfunction. ABI examination is a simple and cost-effective method for obtaining the additional information on the initial step of atherosclerosis beyond the assessment of peripheral artery disease.CONCLUSIONSABI of 0.91-0.99 is associated with endothelial dysfunction. ABI examination is a simple and cost-effective method for obtaining the additional information on the initial step of atherosclerosis beyond the assessment of peripheral artery disease. Background: An ankle-brachial index (ABI) value of 0.91–0.99 is considered borderline and associated with an increased risk of cardiovascular events. However, there is no information on the relationship between borderline ABI and endothelial function. Methods and Results: We measured ABI and assessed vascular function by flow-mediated vasodilation (FMD) and nitroglycerin-induced vasodilation in 389 subjects who underwent health examinations. Subjects were divided into 3 groups according to ABI (normal group: 1.00–1.40, borderline group: 0.91–0.99, abnormal group: ≤0.90 or >1.40). FMD was significantly smaller in both the borderline and the abnormal group than in the normal group. There was no significant difference in the vascular responses to nitroglycerin between the normal and borderline groups. Vascular response to nitroglycerin was significantly higher in the normal group than in the abnormal group. Borderline and abnormal ABI values were significantly associated with an increased odds ratio of low tertile of FMD levels, using the normal ABI group as the reference. Multiple logistic regression analysis for FMD revealed that age, sex, hypertension, diabetes mellitus, and borderline ABI independently remained associated with FMD. Conclusions: ABI of 0.91–0.99 is associated with endothelial dysfunction. ABI examination is a simple and cost-effective method for obtaining the additional information on the initial step of atherosclerosis beyond the assessment of peripheral artery disease. (Circ J 2014; 78: 1740–1745) |
| Author | Nakashima, Ayumu Goto, Chikara Matsumoto, Takeshi Hidaka, Takayuki Iwamoto, Akimichi Kihara, Yasuki Noma, Kensuke Chayama, Kazuaki Maruhashi, Tatsuya Higashi, Yukihito Kajikawa, Masato Iwamoto, Yumiko |
| Author_xml | – sequence: 1 fullname: Hidaka, Takayuki organization: Department of Cardiovascular Medicine, Institute of Biomedical & Health Sciences – sequence: 1 fullname: Maruhashi, Tatsuya organization: Department of Cardiovascular Medicine, Institute of Biomedical & Health Sciences – sequence: 1 fullname: Noma, Kensuke organization: Division of Regeneration and Medicine, Medical Center for Translational and Clinical Research, Hiroshima University Hospital – sequence: 1 fullname: Kihara, Yasuki organization: Department of Cardiovascular Medicine, Institute of Biomedical & Health Sciences – sequence: 1 fullname: Kajikawa, Masato organization: Department of Cardiovascular Medicine, Institute of Biomedical & Health Sciences – sequence: 1 fullname: Iwamoto, Akimichi organization: Department of Cardiovascular Medicine, Institute of Biomedical & Health Sciences – sequence: 1 fullname: Iwamoto, Yumiko organization: Department of Cardiovascular Medicine, Institute of Biomedical & Health Sciences – sequence: 1 fullname: Nakashima, Ayumu organization: Division of Regeneration and Medicine, Medical Center for Translational and Clinical Research, Hiroshima University Hospital – sequence: 1 fullname: Matsumoto, Takeshi organization: Department of Cardiovascular Medicine, Institute of Biomedical & Health Sciences – sequence: 1 fullname: Goto, Chikara organization: Hiroshima International University – sequence: 1 fullname: Chayama, Kazuaki organization: Department of Gastroenterology and Metabolism, Applied Life Science, Institute of Biomedical & Health Sciences – sequence: 1 fullname: Higashi, Yukihito organization: Division of Regeneration and Medicine, Medical Center for Translational and Clinical Research, Hiroshima University Hospital |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/24813179$$D View this record in MEDLINE/PubMed |
| BookMark | eNp9kM1uEzEUhS1U1P89KzRLNhPssWdsL9P0h1SV2ABdWo7nDnFw7GB7BNnxDrxhn4SZJrQICaSre2zpfPdI5wQd-OABoVcET0hV07fGRrOazG5LwkpMmvoFOiaU8ZKJCh88vptSCkaP0ElKK4wriWt5iI4qJgglXB4jdRFiC9FZD8XUf3FQXkRtlla7Yu5b-F580q6HInQFnkjy8OPnILKYp2KaUjBWZ2iLe5uXxZVvQ16CG8nLbep6b7IN_gy97LRLcL7XU_Tx-urD7F159_5mPpvelYZJlktRwwIM1Y0g2khhsBSNwAbDoNAuNO5aYnQlaIcbySssZN3winNDhx8XDT1FZHe39xu9_aadU5to1zpuFcFqLEs9lqWGIUyNZQ3Mmx2zieFrDymrtU0GnNMeQp8UqRmhnAgpB-vrvbVfrKF9uv27yMGAdwYTQ0oRun_Ez27_iG_-QozNeiwtR23d_8DrHbhKWX-GpyQdszUO9gAXio_rGXw2LHVU4Okvel2xcQ |
| CitedBy_id | crossref_primary_10_1186_s40942_023_00521_5 crossref_primary_10_1253_circj_CJ_16_0017 crossref_primary_10_1161_HYPERTENSIONAHA_115_06839 crossref_primary_10_25259_mm_ijcdw_417 crossref_primary_10_1177_00033197241226512 crossref_primary_10_4103_1879_5226_249330 crossref_primary_10_1016_j_ijcard_2016_09_123 crossref_primary_10_3390_jcm14051625 crossref_primary_10_15829_1728_8800_2019_6_136_141 crossref_primary_10_1253_circj_CJ_16_0164 crossref_primary_10_1016_j_acmx_2018_02_009 crossref_primary_10_5551_jat_64639 crossref_primary_10_4082_kjfm_17_0035 crossref_primary_10_1024_0301_1526_a001131 crossref_primary_10_1111_iju_13336 crossref_primary_10_2169_internalmedicine_5401_20 crossref_primary_10_1038_s41598_024_64118_0 crossref_primary_10_3389_fendo_2017_00333 crossref_primary_10_1016_j_atherosclerosis_2016_05_014 crossref_primary_10_1186_s12889_018_5263_6 crossref_primary_10_5758_vsi_200012 crossref_primary_10_1253_circj_CJ_15_0552 crossref_primary_10_4093_dmj_2018_42_1_63 crossref_primary_10_1253_circj_CJ_15_1356 |
| Cites_doi | 10.1253/circj.CJ-13-1330 10.1001/jama.285.19.2486 10.1161/01.CIR.0000095273.92468.D9 10.1161/CIRCULATIONAHA.105.593442 10.1016/j.jns.2008.08.016 10.1056/NEJM199901143400207 10.1161/01.CIR.0000153339.27064.14 10.1001/jama.2012.13415 10.1253/circj.CJ-12-1087 10.1253/circj.CJ-08-1102 10.1161/CIRCULATIONAHA.109.864801 10.1111/j.1532-5415.2008.01633.x 10.1161/01.ATV.0000168911.78624.b7 10.1161/CIRCULATIONAHA.109.865600 10.1161/ATVBAHA.111.227892 10.1016/S0735-1097(98)00206-X 10.1161/HYPERTENSIONAHA.110.163683 10.1016/j.jacc.2010.04.060 10.1016/0140-6736(92)93147-F 10.1016/S0735-1097(02)01976-9 10.1038/clpt.2011.227 10.2337/diacare.22.1.1 10.1161/01.CIR.0000112642.63927.54 10.1161/CIR.0b013e31822e80c3 10.1001/jama.300.2.197 10.1161/01.CIR.0000012543.55874.47 10.1016/0735-1097(94)90141-4 10.1161/CIR.0b013e318276fbcb 10.1161/ATVBAHA.112.300934 10.1016/j.atherosclerosis.2004.08.013 10.1097/00005344-200205000-00007 10.1161/01.CIR.0000112565.60887.1E 10.1016/S0002-9149(00)01321-7 10.1016/j.amjcard.2006.05.056 10.1161/ATVBAHA.112.249680 |
| ContentType | Journal Article |
| Copyright | 2014 THE JAPANESE CIRCULATION SOCIETY |
| Copyright_xml | – notice: 2014 THE JAPANESE CIRCULATION SOCIETY |
| DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 ADTOC UNPAY |
| DOI | 10.1253/circj.CJ-14-0165 |
| DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic Unpaywall for CDI: Periodical Content Unpaywall |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: UNPAY name: Unpaywall url: https://proxy.k.utb.cz/login?url=https://unpaywall.org/ sourceTypes: Open Access Repository |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1347-4820 |
| EndPage | 1745 |
| ExternalDocumentID | 10.1253/circj.cj-14-0165 24813179 10_1253_circj_CJ_14_0165 article_circj_78_7_78_CJ_14_0165_article_char_en |
| Genre | Research Support, Non-U.S. Gov't Journal Article |
| GroupedDBID | --- .55 .GJ 29B 2WC 3O- 53G 5GY 5RE 6J9 ACGFO ADBBV AENEX ALMA_UNASSIGNED_HOLDINGS BAWUL CS3 DIK DU5 E3Z EBS EJD F5P GX1 JSF JSH KQ8 OK1 OVT P2P RJT RNS RZJ TKC TR2 W2D X7M XSB ZXP AAYXX CITATION CGR CUY CVF ECM EIF M~E NPM RYR 7X8 ADTOC UNPAY |
| ID | FETCH-LOGICAL-c494t-85ebec3a681ac98c098680c0e986edba0fd1ca283f06972089567277c39727863 |
| IEDL.DBID | UNPAY |
| ISSN | 1346-9843 1347-4820 |
| IngestDate | Tue Aug 19 21:27:57 EDT 2025 Thu Oct 02 12:02:57 EDT 2025 Thu May 23 23:48:27 EDT 2024 Tue Jul 01 02:01:12 EDT 2025 Thu Apr 24 23:00:35 EDT 2025 Wed Sep 03 06:24:09 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 7 |
| Language | English |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c494t-85ebec3a681ac98c098680c0e986edba0fd1ca283f06972089567277c39727863 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
| OpenAccessLink | https://proxy.k.utb.cz/login?url=https://www.jstage.jst.go.jp/article/circj/78/7/78_CJ-14-0165/_pdf |
| PMID | 24813179 |
| PQID | 1541371899 |
| PQPubID | 23479 |
| PageCount | 6 |
| ParticipantIDs | unpaywall_primary_10_1253_circj_cj_14_0165 proquest_miscellaneous_1541371899 pubmed_primary_24813179 crossref_primary_10_1253_circj_CJ_14_0165 crossref_citationtrail_10_1253_circj_CJ_14_0165 jstage_primary_article_circj_78_7_78_CJ_14_0165_article_char_en |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2014-00-00 |
| PublicationDateYYYYMMDD | 2014-01-01 |
| PublicationDate_xml | – year: 2014 text: 2014-00-00 |
| PublicationDecade | 2010 |
| PublicationPlace | Japan |
| PublicationPlace_xml | – name: Japan |
| PublicationTitle | Circulation Journal |
| PublicationTitleAlternate | Circ J |
| PublicationYear | 2014 |
| Publisher | The Japanese Circulation Society |
| Publisher_xml | – name: The Japanese Circulation Society |
| References | 12. Modena MG, Bonetti L, Coppi F, Bursi F, Rossi R. Prognostic role of reversible endothelial dysfunction in hypertensive postmenopausal women. J Am Coll Cardiol 2002; 40: 505–510. 20. McDermott MM, Tian L, Ferrucci L, Liu K, Guralnik JM, Liao Y, et al. Associations between lower extremity ischemia, upper and lower extremity strength, and functional impairment with peripheral arterial disease. J Am Geriatr Soc 2008; 56: 724–729. 2. Higashi Y, Noma K, Yoshizumi M, Kihara Y. Oxidative stress and endothelial function in cardiovascular diseases (Review). Circ J 2009; 73: 411–418. 29. Iwamoto Y, Maruhashi T, Fujii Y, Idei N, Fujimura N, Mikami S, et al. Intima-media thickness of brachial artery, endothelial function, and cardiovascular risk factors. Arterioscler Thromb Vasc Biol 2012; 32: 2295–2303. 16. Yeboah J, Folsom AR, Burke GL, Johnson C, Polak JF, Post W, et al. Predictive value of brachial flow-mediated dilation for incident cardiovascular events in a population-based study: The multi-ethnic study of atherosclerosis. Circulation 2009; 120: 502–509. 19. Diehm C, Allenberg JR, Pittrow D, Mahn M, Tepohl G, Haberl RL, et al. Mortality and vascular morbidity in older adults with asymptomatic versus symptomatic peripheral artery disease. Circulation 2009; 120: 2053–2061. 33. Joosten MM, Pai JK, Bertoia ML, Rimm EB, Spiegelman D, Mittleman MA, et al. Associations between conventional cardiovascular risk factors and risk of peripheral artery disease in men. JAMA 2012; 308: 1660–1667. 8. Fujimura N, Noma K, Hata T, Hidaka T, Idei N, Fujii Y, et al. Mineralocorticoid receptor blocker eplerenone improves endothelial function and inhibits Rho-associated kinase activity in patients with hypertension. Clin Pharmacol Ther 2012; 91: 289–297. 11. Raitakari OT, Seale JP, Celermajer DS. Impaired vascular responses to nitroglycerin in subjects with coronary atherosclerosis. Am J Cardiol 2001; 87: 217–219, A8. 26. Ovbiagele B. Association of ankle-brachial index level with stroke. J Neurol Sci 2009; 276: 14–17. 35. Criqui MH, McClelland RL, McDermott MM, Allison MA, Blumenthal RS, Aboyans V, et al. The ankle-brachial index and incident cardiovascular events in the MESA (Multi-Ethnic Study of Atherosclerosis). J Am Coll Cardiol 2010; 56: 1506–1512. 1. Ross R. Atherosclerosis: An inflammatory disease. N Engl J Med 1999; 340: 115–126. 15. Lerman A, Zeiher AM. Endothelial function: Cardiac events. Circulation 2005; 111: 363–368. 18. Golomb BA, Dang TT, Criqui MH. Peripheral arterial disease: Morbidity and mortality implications. Circulation 2006; 114: 688–699. 5. Benjamin EJ, Larson MG, Keyes MJ, Mitchell GF, Vasan RS, Keaney JF Jr, et al. Clinical correlates and heritability of flow-mediated dilation in the community: The Framingham Heart Study. Circulation 2004; 109: 613–619. 28. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001; 285: 2486–2497. 22. Aboyans V, Criqui MH, Abraham P, Allison MA, Creager MA, Diehm C, et al. Measurement and interpretation of the ankle-brachial index: A scientific statement from the American Heart Association. Circulation 2012; 126: 2890–2909. 17. Doobay AV, Anand SS. Sensitivity and specificity of the ankle-brachial index to predict future cardiovascular outcomes: A systematic review. Arterioscler Thromb Vasc Biol 2005; 25: 1463–1469. 4. Celermajer DS, Sorensen KE, Bull C, Robinson J, Deanfield JE. Endothelium-dependent dilation in the systemic arteries of asymptomatic subjects relates to coronary risk factors and their interaction. J Am Coll Cardiol 1994; 24: 1468–1474. 3. Celermajer DS, Sorensen KE, Gooch VM, Spiegelhalter DJ, Miller OI, Sullivan ID, et al. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet 1992; 340: 1111–1115. 32. Sanada H, Higashi Y, Goto C, Chayama K, Yoshizumi M, Sueda T. Vascular function in patients with lower extremity peripheral arterial disease: A comparison of functions in upper and lower extremities. Atherosclerosis 2005; 178: 179–185. 9. Kajikawa M, Nakashima A, Maruhashi T, Iwamoto Y, Iwamoto A, Matsumoto T, et al. Poor oral health, that is, Decreased frequency of tooth brushing, is associated with endothelial dysfunction. Circ J 2014; 78: 950–954. 27. American Diabetes Association. Clinical practice recommendations 1999. Diabetes Care 1999; 22(Suppl 1): S1–S114. 30. Higashi Y, Sasaki S, Nakagawa K, Kimura M, Sasaki S, Noma K, et al. The severity of hypertension affects improved resistance artery endothelial function by angiotensin converting enzyme inhibition. J Cardiovasc Pharmacol 2002; 39: 668–676. 10. Adams MR, Robinson J, McCredie R, Seale JP, Sorensen KE, Deanfield JE, et al. Smooth muscle dysfunction occurs independently of impaired endothelium-dependent dilation in adults at risk of atherosclerosis. J Am Coll Cardiol 1998; 32: 123–127. 7. Soga J, Noma K, Hata T, Hidaka T, Fujii Y, Idei N, et al. Rho-associated kinase activity, endothelial function, and cardiovascular risk factors. Arterioscler Thromb Vasc Biol 2011; 31: 2353–2359. 6. Idei N, Nishioka K, Soga J, Hidaka T, Hata T, Fujii Y, et al. Vascular function and circulating progenitor cells in thromboangitis obliterans (Buerger’s disease) and atherosclerosis obliterans. Hypertension 2011; 57: 70–78. 31. Maruhashi T, Soga J, Fujimura N, Idei N, Mikami S, Iwamoto Y, et al. Nitroglycerine-induced vasodilation for assessment of vascular function: A comparison with flow-mediated vasodilation. Arterioscler Thromb Vasc Biol 2013; 33: 1401–1408. 23. Rooke TW, Hirsch AT, Misra S, Sidawy AN, Beckman JA, Findeiss LK, et al. 2011 ACCF/AHA Focused Update of the Guideline for the Management of patients with peripheral artery disease (Updating the 2005 Guideline): A report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Circulation 2011; 124: 2020–2045. 14. Brevetti G, Silvestro A, Schiano V, Chiariello M. Endothelial dysfunction and cardiovascular risk prediction in peripheral arterial disease: Additive value of flow-mediated dilation to ankle-brachial pressure index. Circulation 2003; 108: 2093–2098. 34. Resnick HE, Lindsay RS, McDermott MM, Devereux RB, Jones KL, Fabsitz RR, et al. Relationship of high and low ankle brachial index to all-cause and cardiovascular disease mortality: The Strong Heart Study. Circulation 2004; 109: 733–739. 21. Ikeda N, Kogame N, Iijima R, Nakamura M, Sugi K. Impact of carotid artery ultrasound and ankle-brachial index on prediction of severity of SYNTAX score. Circ J 2013; 77: 712–716. 25. Ankle Brachial Index Collaboration, Fowkes FG, Murray GD, Butcher I, Heald CL, Lee RJ, Chambless LE, et al. Ankle brachial index combined with Framingham Risk Score to predict cardiovascular events and mortality: A meta-analysis. JAMA 2008; 300: 197–208. 13. Gokce N, Keaney JF Jr, Hunter LM, Watkins MT, Menzoian JO, Vita JA. Risk stratification for postoperative cardiovascular events via noninvasive assessment of endothelial function: A prospective study. Circulation 2002; 105: 1567–1572. 24. Menke A, Muntner P, Wildman RP, Dreisbach AW, Raggi P. Relation of borderline peripheral arterial disease to cardiovascular disease risk. Am J Cardiol 2006; 98: 1226–1230. 22 23 24 25 26 27 28 29 30 31 10 32 11 33 12 34 13 35 14 15 16 17 18 19 1 2 3 4 5 6 7 8 9 20 21 |
| References_xml | – reference: 19. Diehm C, Allenberg JR, Pittrow D, Mahn M, Tepohl G, Haberl RL, et al. Mortality and vascular morbidity in older adults with asymptomatic versus symptomatic peripheral artery disease. Circulation 2009; 120: 2053–2061. – reference: 29. Iwamoto Y, Maruhashi T, Fujii Y, Idei N, Fujimura N, Mikami S, et al. Intima-media thickness of brachial artery, endothelial function, and cardiovascular risk factors. Arterioscler Thromb Vasc Biol 2012; 32: 2295–2303. – reference: 6. Idei N, Nishioka K, Soga J, Hidaka T, Hata T, Fujii Y, et al. Vascular function and circulating progenitor cells in thromboangitis obliterans (Buerger’s disease) and atherosclerosis obliterans. Hypertension 2011; 57: 70–78. – reference: 5. Benjamin EJ, Larson MG, Keyes MJ, Mitchell GF, Vasan RS, Keaney JF Jr, et al. Clinical correlates and heritability of flow-mediated dilation in the community: The Framingham Heart Study. Circulation 2004; 109: 613–619. – reference: 12. Modena MG, Bonetti L, Coppi F, Bursi F, Rossi R. Prognostic role of reversible endothelial dysfunction in hypertensive postmenopausal women. J Am Coll Cardiol 2002; 40: 505–510. – reference: 15. Lerman A, Zeiher AM. Endothelial function: Cardiac events. Circulation 2005; 111: 363–368. – reference: 31. Maruhashi T, Soga J, Fujimura N, Idei N, Mikami S, Iwamoto Y, et al. Nitroglycerine-induced vasodilation for assessment of vascular function: A comparison with flow-mediated vasodilation. Arterioscler Thromb Vasc Biol 2013; 33: 1401–1408. – reference: 13. Gokce N, Keaney JF Jr, Hunter LM, Watkins MT, Menzoian JO, Vita JA. Risk stratification for postoperative cardiovascular events via noninvasive assessment of endothelial function: A prospective study. Circulation 2002; 105: 1567–1572. – reference: 32. Sanada H, Higashi Y, Goto C, Chayama K, Yoshizumi M, Sueda T. Vascular function in patients with lower extremity peripheral arterial disease: A comparison of functions in upper and lower extremities. Atherosclerosis 2005; 178: 179–185. – reference: 2. Higashi Y, Noma K, Yoshizumi M, Kihara Y. Oxidative stress and endothelial function in cardiovascular diseases (Review). Circ J 2009; 73: 411–418. – reference: 30. Higashi Y, Sasaki S, Nakagawa K, Kimura M, Sasaki S, Noma K, et al. The severity of hypertension affects improved resistance artery endothelial function by angiotensin converting enzyme inhibition. J Cardiovasc Pharmacol 2002; 39: 668–676. – reference: 1. Ross R. Atherosclerosis: An inflammatory disease. N Engl J Med 1999; 340: 115–126. – reference: 11. Raitakari OT, Seale JP, Celermajer DS. Impaired vascular responses to nitroglycerin in subjects with coronary atherosclerosis. Am J Cardiol 2001; 87: 217–219, A8. – reference: 26. Ovbiagele B. Association of ankle-brachial index level with stroke. J Neurol Sci 2009; 276: 14–17. – reference: 33. Joosten MM, Pai JK, Bertoia ML, Rimm EB, Spiegelman D, Mittleman MA, et al. Associations between conventional cardiovascular risk factors and risk of peripheral artery disease in men. JAMA 2012; 308: 1660–1667. – reference: 4. Celermajer DS, Sorensen KE, Bull C, Robinson J, Deanfield JE. Endothelium-dependent dilation in the systemic arteries of asymptomatic subjects relates to coronary risk factors and their interaction. J Am Coll Cardiol 1994; 24: 1468–1474. – reference: 25. Ankle Brachial Index Collaboration, Fowkes FG, Murray GD, Butcher I, Heald CL, Lee RJ, Chambless LE, et al. Ankle brachial index combined with Framingham Risk Score to predict cardiovascular events and mortality: A meta-analysis. JAMA 2008; 300: 197–208. – reference: 9. Kajikawa M, Nakashima A, Maruhashi T, Iwamoto Y, Iwamoto A, Matsumoto T, et al. Poor oral health, that is, Decreased frequency of tooth brushing, is associated with endothelial dysfunction. Circ J 2014; 78: 950–954. – reference: 27. American Diabetes Association. Clinical practice recommendations 1999. Diabetes Care 1999; 22(Suppl 1): S1–S114. – reference: 18. Golomb BA, Dang TT, Criqui MH. Peripheral arterial disease: Morbidity and mortality implications. Circulation 2006; 114: 688–699. – reference: 3. Celermajer DS, Sorensen KE, Gooch VM, Spiegelhalter DJ, Miller OI, Sullivan ID, et al. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet 1992; 340: 1111–1115. – reference: 20. McDermott MM, Tian L, Ferrucci L, Liu K, Guralnik JM, Liao Y, et al. Associations between lower extremity ischemia, upper and lower extremity strength, and functional impairment with peripheral arterial disease. J Am Geriatr Soc 2008; 56: 724–729. – reference: 14. Brevetti G, Silvestro A, Schiano V, Chiariello M. Endothelial dysfunction and cardiovascular risk prediction in peripheral arterial disease: Additive value of flow-mediated dilation to ankle-brachial pressure index. Circulation 2003; 108: 2093–2098. – reference: 8. Fujimura N, Noma K, Hata T, Hidaka T, Idei N, Fujii Y, et al. Mineralocorticoid receptor blocker eplerenone improves endothelial function and inhibits Rho-associated kinase activity in patients with hypertension. Clin Pharmacol Ther 2012; 91: 289–297. – reference: 23. Rooke TW, Hirsch AT, Misra S, Sidawy AN, Beckman JA, Findeiss LK, et al. 2011 ACCF/AHA Focused Update of the Guideline for the Management of patients with peripheral artery disease (Updating the 2005 Guideline): A report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Circulation 2011; 124: 2020–2045. – reference: 28. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001; 285: 2486–2497. – reference: 21. Ikeda N, Kogame N, Iijima R, Nakamura M, Sugi K. Impact of carotid artery ultrasound and ankle-brachial index on prediction of severity of SYNTAX score. Circ J 2013; 77: 712–716. – reference: 35. Criqui MH, McClelland RL, McDermott MM, Allison MA, Blumenthal RS, Aboyans V, et al. The ankle-brachial index and incident cardiovascular events in the MESA (Multi-Ethnic Study of Atherosclerosis). J Am Coll Cardiol 2010; 56: 1506–1512. – reference: 7. Soga J, Noma K, Hata T, Hidaka T, Fujii Y, Idei N, et al. Rho-associated kinase activity, endothelial function, and cardiovascular risk factors. Arterioscler Thromb Vasc Biol 2011; 31: 2353–2359. – reference: 16. Yeboah J, Folsom AR, Burke GL, Johnson C, Polak JF, Post W, et al. Predictive value of brachial flow-mediated dilation for incident cardiovascular events in a population-based study: The multi-ethnic study of atherosclerosis. Circulation 2009; 120: 502–509. – reference: 17. Doobay AV, Anand SS. Sensitivity and specificity of the ankle-brachial index to predict future cardiovascular outcomes: A systematic review. Arterioscler Thromb Vasc Biol 2005; 25: 1463–1469. – reference: 22. Aboyans V, Criqui MH, Abraham P, Allison MA, Creager MA, Diehm C, et al. Measurement and interpretation of the ankle-brachial index: A scientific statement from the American Heart Association. Circulation 2012; 126: 2890–2909. – reference: 24. Menke A, Muntner P, Wildman RP, Dreisbach AW, Raggi P. Relation of borderline peripheral arterial disease to cardiovascular disease risk. Am J Cardiol 2006; 98: 1226–1230. – reference: 10. Adams MR, Robinson J, McCredie R, Seale JP, Sorensen KE, Deanfield JE, et al. Smooth muscle dysfunction occurs independently of impaired endothelium-dependent dilation in adults at risk of atherosclerosis. J Am Coll Cardiol 1998; 32: 123–127. – reference: 34. Resnick HE, Lindsay RS, McDermott MM, Devereux RB, Jones KL, Fabsitz RR, et al. Relationship of high and low ankle brachial index to all-cause and cardiovascular disease mortality: The Strong Heart Study. Circulation 2004; 109: 733–739. – ident: 9 doi: 10.1253/circj.CJ-13-1330 – ident: 28 doi: 10.1001/jama.285.19.2486 – ident: 14 doi: 10.1161/01.CIR.0000095273.92468.D9 – ident: 18 doi: 10.1161/CIRCULATIONAHA.105.593442 – ident: 26 doi: 10.1016/j.jns.2008.08.016 – ident: 1 doi: 10.1056/NEJM199901143400207 – ident: 15 doi: 10.1161/01.CIR.0000153339.27064.14 – ident: 33 doi: 10.1001/jama.2012.13415 – ident: 21 doi: 10.1253/circj.CJ-12-1087 – ident: 2 doi: 10.1253/circj.CJ-08-1102 – ident: 16 doi: 10.1161/CIRCULATIONAHA.109.864801 – ident: 20 doi: 10.1111/j.1532-5415.2008.01633.x – ident: 17 doi: 10.1161/01.ATV.0000168911.78624.b7 – ident: 19 doi: 10.1161/CIRCULATIONAHA.109.865600 – ident: 7 doi: 10.1161/ATVBAHA.111.227892 – ident: 10 doi: 10.1016/S0735-1097(98)00206-X – ident: 6 doi: 10.1161/HYPERTENSIONAHA.110.163683 – ident: 35 doi: 10.1016/j.jacc.2010.04.060 – ident: 3 doi: 10.1016/0140-6736(92)93147-F – ident: 12 doi: 10.1016/S0735-1097(02)01976-9 – ident: 8 doi: 10.1038/clpt.2011.227 – ident: 27 doi: 10.2337/diacare.22.1.1 – ident: 34 doi: 10.1161/01.CIR.0000112642.63927.54 – ident: 23 doi: 10.1161/CIR.0b013e31822e80c3 – ident: 25 doi: 10.1001/jama.300.2.197 – ident: 13 doi: 10.1161/01.CIR.0000012543.55874.47 – ident: 4 doi: 10.1016/0735-1097(94)90141-4 – ident: 22 doi: 10.1161/CIR.0b013e318276fbcb – ident: 31 doi: 10.1161/ATVBAHA.112.300934 – ident: 32 doi: 10.1016/j.atherosclerosis.2004.08.013 – ident: 30 doi: 10.1097/00005344-200205000-00007 – ident: 5 doi: 10.1161/01.CIR.0000112565.60887.1E – ident: 11 doi: 10.1016/S0002-9149(00)01321-7 – ident: 24 doi: 10.1016/j.amjcard.2006.05.056 – ident: 29 doi: 10.1161/ATVBAHA.112.249680 |
| SSID | ssj0029059 |
| Score | 2.2035036 |
| Snippet | Background: An ankle-brachial index (ABI) value of 0.91–0.99 is considered borderline and associated with an increased risk of cardiovascular events. However,... An ankle-brachial index (ABI) value of 0.91-0.99 is considered borderline and associated with an increased risk of cardiovascular events. However, there is no... |
| SourceID | unpaywall proquest pubmed crossref jstage |
| SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 1740 |
| SubjectTerms | Adult Aged Ankle Brachial Index - methods Ankle-brachial index Endothelial function Female Humans Intima-media thickness Male Middle Aged Nitroglycerin - administration & dosage Peripheral Arterial Disease - diagnosis Peripheral Arterial Disease - physiopathology Peripheral artery disease Tunica Intima - physiopathology Vascular smooth muscle function Vasodilation Vasodilator Agents - administration & dosage |
| Title | Borderline Ankle-Brachial Index Value of 0.91–0.99 Is Associated With Endothelial Dysfunction |
| URI | https://www.jstage.jst.go.jp/article/circj/78/7/78_CJ-14-0165/_article/-char/en https://www.ncbi.nlm.nih.gov/pubmed/24813179 https://www.proquest.com/docview/1541371899 https://www.jstage.jst.go.jp/article/circj/78/7/78_CJ-14-0165/_pdf |
| UnpaywallVersion | publishedVersion |
| Volume | 78 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| ispartofPNX | Circulation Journal, 2014, Vol.78(7), pp.1740-1745 |
| journalDatabaseRights | – providerCode: PRVAFT databaseName: Open Access Digital Library customDbUrl: eissn: 1347-4820 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0029059 issn: 1347-4820 databaseCode: KQ8 dateStart: 20020101 isFulltext: true titleUrlDefault: http://grweb.coalliance.org/oadl/oadl.html providerName: Colorado Alliance of Research Libraries – providerCode: PRVBFR databaseName: Free Medical Journals customDbUrl: eissn: 1347-4820 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0029059 issn: 1347-4820 databaseCode: DIK dateStart: 20020101 isFulltext: true titleUrlDefault: http://www.freemedicaljournals.com providerName: Flying Publisher – providerCode: PRVFQY databaseName: GFMER Free Medical Journals customDbUrl: eissn: 1347-4820 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0029059 issn: 1347-4820 databaseCode: GX1 dateStart: 0 isFulltext: true titleUrlDefault: http://www.gfmer.ch/Medical_journals/Free_medical.php providerName: Geneva Foundation for Medical Education and Research |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwEB7RLYJy4E1ZHlWQuIDkPJ3YPqFtaWkrUXFgYXuyHMfbNo2yq91EqJz4D_xDfgnjPJaCAAlxiQ-Z8WvGmW_i8RjgOY9DhXaAkjQyGaFpxoliqSCBMcIIu7pMk-3zKNkf08NJPLl0FsaGVeaIi06MLdyTmZvPvW4SPX220LnHuMfwIXcOSWAjKJLYk_NsugbrSYx4fADr46N3o-PG06IJEbyNso8oIxTtXbdXGcZRW5-r876en2zT1bYbv0OeN-B6Xc7VxSdVFJes0d4t0P042iCUc7euUld__iXF4_8N9Dbc7MCqM2rp78AVU96Fa2-77fh7ILebzJ0WqTqj8rwwZHthgzOR58BmYXQ-qKI2zmzq-K4Ivn35ioVwDpZOrxQmcz6eVafObpnZk2CF5Xx9sbTG1irMfRjv7b7f2SfdjQ1EU0ErwmOrE5FKeKC04NoXPOG-9g2WJkuVP80CrRDRTP1EsNDn6J0hgGIaUVHIeBI9gEE5K81DcBB3-YLhe3tHL1NUoYmNWJSoMOUhYrwheL2spO7SmdtbNQpp3RqUrmwmEScPvRtpJ28IL1Yc8zaVx19oX7XCWVF2oukoUSpMNqLpOX4QnKoFfnKG8KzXG4kr1m7DqNLM6qVE0BpECAmEGMJmq1CrVkLKA0R0-OblSsP-0Fmd900_-hfix7CBmI-2f5GewKBa1OYp4qoq3YK1N5Ngq1s-3wF3nx9F |
| linkProvider | Unpaywall |
| linkToUnpaywall | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwEB7BFvE48H4sLxmJC0jO04ntE9qWVm0lKg4slJPlON62aZRd7SZC5cR_4B_ySxjnsRQESIhLfMiMXzPOfBOPxwDPRRJptAOMZrHNKctyQTXPJA2tlVa61WXbbJ8H6e6U7R8mh-fOwriwygJx0ZF1hXc094qF30-ib06WpvC58Dk-1NY-DV0ERZr4apHPLsJGmiAeH8HG9ODt5GPrabGUStFF2ceMU4b2rt-rjJK4q88zxVDPT7bpUteN3yHPa3ClqRb67JMuy3PWaOcGmGEcXRDKqdfUmWc-_5Li8f8GehOu92CVTDr6W3DBVrfh8pt-O_4OqM02c6dDqmRSnZaWbi5dcCby7LksjOS9LhtL5jMSeDL89uUrFpLsrcigFDYnH07qY7Jd5e4kWOk4X5-tnLF1CnMXpjvb77Z2aX9jAzVMspqKxOlErFMRaiOFCaRIRWACi6XNMx3M8tBoRDSzIJU8CgR6ZwiguEFUFHGRxvdgVM0r-wAI4q5Acnzv7ujlmmk0sTGPUx1lIkKMNwZ_kJUyfTpzd6tGqZxbg9JV7STi5KF3o9zkjeHFmmPRpfL4C-2rTjhryl40PSVKhatWNAPHD4JjvcRPzhieDXqjcMW6bRhd2XmzUghawxghgZRjuN8p1LqViIkQER2-ebnWsD901hRD0w__hfgRXEXMx7q_SI9hVC8b-wRxVZ097RfOd8G6HlQ |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Borderline+Ankle-Brachial+Index+Value+of+0.91%E2%80%930.99+Is+Associated+With+Endothelial+Dysfunction&rft.jtitle=Circulation+Journal&rft.au=Hidaka%2C+Takayuki&rft.au=Maruhashi%2C+Tatsuya&rft.au=Noma%2C+Kensuke&rft.au=Kihara%2C+Yasuki&rft.date=2014&rft.pub=The+Japanese+Circulation+Society&rft.issn=1346-9843&rft.eissn=1347-4820&rft.volume=78&rft.issue=7&rft.spage=1740&rft.epage=1745&rft_id=info:doi/10.1253%2Fcircj.CJ-14-0165&rft.externalDocID=article_circj_78_7_78_CJ_14_0165_article_char_en |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1346-9843&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1346-9843&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1346-9843&client=summon |